{"id":815237,"date":"2025-02-19T17:26:40","date_gmt":"2025-02-19T22:26:40","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-shareholder-class-action-lawsuit-filed-against-transmedics-group-inc-nasdaq-tmdx-dicello-levitt-llp-encourages-investors-with-losses-to-discuss-their-options-with-counsel\/"},"modified":"2025-02-19T17:26:40","modified_gmt":"2025-02-19T22:26:40","slug":"investor-alert-shareholder-class-action-lawsuit-filed-against-transmedics-group-inc-nasdaq-tmdx-dicello-levitt-llp-encourages-investors-with-losses-to-discuss-their-options-with-counsel","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-shareholder-class-action-lawsuit-filed-against-transmedics-group-inc-nasdaq-tmdx-dicello-levitt-llp-encourages-investors-with-losses-to-discuss-their-options-with-counsel\/","title":{"rendered":"INVESTOR ALERT: Shareholder Class Action Lawsuit Filed Against TransMedics Group, Inc. (NASDAQ: TMDX); DiCello Levitt LLP Encourages Investors with Losses to Discuss Their Options with Counsel"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">SAN DIEGO, Feb.  19, 2025  (GLOBE NEWSWIRE) &#8212; A class action lawsuit has been filed on behalf of all persons and entities who purchased or otherwise acquired TransMedics Group, Inc. (NASDAQ: TMDX) (\u201cTransMedics\u201d or the \u201cCompany\u201d) securities between February 28, 2023 and January 10, 2025 (the \u201cClass Period\u201d), charging the Company and certain senior executives with violations of the federal securities laws (collectively, \u201cDefendants\u201d).<\/p>\n<p align=\"justify\">TransMedics investors have until April 15, 2025 to seek appointment as lead plaintiff of the TransMedics class action lawsuit.<\/p>\n<p align=\"justify\">\n        <strong><br \/>\n          <em>If you purchased or acquired TransMedics securities between February 28, 2023 and January 10, 2025, and suffered substantial losses<\/em><br \/>\n        <\/strong>, and you wish to obtain additional information or serve as lead plaintiff in this lawsuit, you may <strong><em>submit your information and contact us here: <\/em><\/strong><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=pwuSHVuNjlnIfKaqvl3Wc0URSMtHxpocAXuWkz9rVr9HgHtX_ND3O7FKX4wdr8N5vytXq9gkzVkMrXwl8wy-ao-3DbeiU4p0xGx_ZbL9BxvhY59yKazKXJmVhQYzDUlwpNjjsxGmmygdF4wBF2uZ3tGNLPZfYbs8uXzrj5RCWlw=\" rel=\"nofollow\" target=\"_blank\">https:\/\/dicellolevitt.com\/securities\/transmedics\/<\/a>.<\/p>\n<p align=\"justify\">You can also contact DiCello Levitt attorneys Brian O\u2019Mara or Ruben Pe\u00f1a by calling (888) 287-9005 or emailing <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Fxx2Df3ULy87b8j3LkkRjUs2-IPCNScA2D-c_dTAcY-z210-RhEdK8tZhZoEXyaL2NWdwQNRcTzvvh8L1AAqJFQuvvZeGj5BeMuJWSgAk4BWnQg5ciuUV5Nq0lpk2x7W\" rel=\"nofollow\" target=\"_blank\">investors@dicellolevitt.com<\/a>. Those who inquire by email are encouraged to include their mailing address, telephone number, and the number of shares purchased.<\/p>\n<p align=\"justify\">No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice.<\/p>\n<p align=\"justify\">\n        <strong>Case Allegations<\/strong>\n      <\/p>\n<p align=\"justify\">TransMedics is a commercial-stage medical technology company transforming organ transplant therapy for end-stage lung, heart, and liver failure patients. The Company developed the Organ Care System (\u201cOCS\u201d) to transform organ preservation by replicating many aspects of the organ\u2019s natural living and functioning environment outside of the human body. TransMedics\u2019 logistics services include aviation transportation, ground transportation, and other coordination activities.<\/p>\n<p align=\"justify\">The TransMedics lawsuit alleges that Defendants made materially false and\/or misleading statements during the Class Period about the Company\u2019s business, operations, and prospects. Specifically, Defendants failed to disclose that: (1) TransMedics used kickbacks, fraudulent overbilling, and coercive tactics to generate business and revenue; (2) TransMedics engaged in unsafe practices, hid safety issues, and generally lacked safety oversight; and (3) the foregoing subjected TransMedics to heightened risk of scrutiny and regulatory risk.<\/p>\n<p align=\"justify\">The truth began to emerge on February 21, 2024 when U.S. Representative Paul Gosar issued a letter accusing TransMedics of misconduct, including that \u201c<strong><em>TransMedics is not a collaborative partner in transplantation as administrators continue to push back against its coercive tactics<\/em><\/strong>.\u201d The next day, <em>The Daily Caller<\/em> published an article highlighting the allegations in Representative Gosar\u2019s letter, noting that \u201c<strong><em>TransMedics Aviation carries significantly higher costs than [hospitals\u2019] current providers. Some transplant centers have reported being pressured to use TransMedics\u2019 captive aircraft, at nearly double the cost, or risk losing access to TransMedics\u2019 life saving device.<\/em><\/strong>\u201d<\/p>\n<p align=\"justify\">On this news, the price of TransMedics stock fell by $2.18 per share, or 2.5%, to close at $84.81 per share on February 22, 2024.<\/p>\n<p align=\"justify\">The truth was fully revealed on January 10, 2025 when <em>Scorpion Capital<\/em> issued a scathing report about TransMedics (the \u201cReport\u201d), claiming the Company overbills hospitals that use its services; stating the Company provides patients with organs previously rejected by reputable physicians through physicians who TransMedics paid; and verifying the allegations in Representative Gosar\u2019s letter. In particular, the Report details the Company\u2019s \u201c<strong><em>OCS Liver, [is] a gimmick used not for any clinical benefit but for a) off-label use for scheduling [and] b) by questionable centers whom we believe receive kickbacks and organs in exchange for taking them on the device<\/em><\/strong>\u201d; \u201c<strong><em>TransMedics OCS devices are plagued by failures leading to the loss of a significant percentage of organs<\/em><\/strong>\u201d; and \u201c<strong><em>TransMedics data was always under scrutiny because of multiple violations . . . and warning letters . . . because the [U.S. Food and Drug Administration] was aware that they are not conducting themselves in the most honest manner<\/em><\/strong>.\u201d<\/p>\n<p align=\"justify\">On this news, the price of TransMedics stock fell by $3.74 per share, or 5.15%, to close at $68.81 per share on January 10, 2025. TransMedics stock then fell a further $4.76 per share, or 6.9%, to close at $64.05 per share on January 13, 2025.<\/p>\n<p align=\"justify\">\n        <strong>About DiCello Levitt<\/strong>\n      <\/p>\n<p align=\"justify\">At DiCello Levitt, we are dedicated to achieving justice for our clients through class action, business-to-business, public client, whistleblower, personal injury, civil and human rights, and mass tort litigation. Our lawyers are highly respected for their ability to litigate and win cases \u2013 whether by trial, settlement, or otherwise \u2013 for people who have suffered harm, global corporations that have sustained significant economic losses, and public clients seeking to protect their citizens\u2019 rights and interests. Every day, we put our reputations \u2013 and our capital \u2013 on the line for our clients.<\/p>\n<p align=\"justify\">DiCello Levitt has achieved top recognition as Plaintiffs Firm of the Year and Trial Innovation Firm of the Year by the <em>National Law Journal<\/em>, in addition to its top-tier <em>Chambers<\/em> and <em>Benchmark<\/em> ratings. The <em>New York Law Journal<\/em> also recently recognized DiCello Levitt as a Distinguished Leader in trial innovation. For more information about the Firm, including recent trial victories and case resolutions, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=YeoOMKbU5EG0cZSRjnBfAH0uFv29Cwdnhg5p-87e07hOON4SZ6TvCsdfwK_gT_wU0wr-ffKdeZ7xLwVBVoWK5mxJaovYeRjS4gxdrs-_7Es=\" rel=\"nofollow\" target=\"_blank\">www.dicellolevitt.com<\/a>.<\/p>\n<p align=\"justify\">Attorney Advertising. Prior results do not guarantee a similar outcome.<\/p>\n<p align=\"justify\">\n        <strong>Media Contact<\/strong>\n      <\/p>\n<p align=\"justify\">Amy Coker<br \/>4747 Executive Drive, Suite 240<br \/>San Diego, CA 92121<br \/>619-963-2426<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Fxx2Df3ULy87b8j3LkkRjUs2-IPCNScA2D-c_dTAcY-ZYVX3Nr0sYJxy8uqZRtvdcVKzPsWwQKLCmu_KCalmFJnQrTkeaBoDA6LaJDQADq5aVUKqDG2Vk5fXySJpBZL5\" rel=\"nofollow\" target=\"_blank\">investors@dicellolevitt.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MTM1OSM2NzU5NDU2IzIyNzUwODI=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MDE3NmUxOTYtZGJiMy00ZDgyLWE1NDEtYTZmMWIzYmI2NGM2LTEyODY2MzI=\/tiny\/DiCello-Levitt-LLP.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SAN DIEGO, Feb. 19, 2025 (GLOBE NEWSWIRE) &#8212; A class action lawsuit has been filed on behalf of all persons and entities who purchased or otherwise acquired TransMedics Group, Inc. (NASDAQ: TMDX) (\u201cTransMedics\u201d or the \u201cCompany\u201d) securities between February 28, 2023 and January 10, 2025 (the \u201cClass Period\u201d), charging the Company and certain senior executives with violations of the federal securities laws (collectively, \u201cDefendants\u201d). TransMedics investors have until April 15, 2025 to seek appointment as lead plaintiff of the TransMedics class action lawsuit. If you purchased or acquired TransMedics securities between February 28, 2023 and January 10, 2025, and suffered substantial losses , and you wish to obtain additional information or serve as lead plaintiff in this lawsuit, you may &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-shareholder-class-action-lawsuit-filed-against-transmedics-group-inc-nasdaq-tmdx-dicello-levitt-llp-encourages-investors-with-losses-to-discuss-their-options-with-counsel\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;INVESTOR ALERT: Shareholder Class Action Lawsuit Filed Against TransMedics Group, Inc. (NASDAQ: TMDX); DiCello Levitt LLP Encourages Investors with Losses to Discuss Their Options with Counsel&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-815237","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>INVESTOR ALERT: Shareholder Class Action Lawsuit Filed Against TransMedics Group, Inc. (NASDAQ: TMDX); DiCello Levitt LLP Encourages Investors with Losses to Discuss Their Options with Counsel - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-shareholder-class-action-lawsuit-filed-against-transmedics-group-inc-nasdaq-tmdx-dicello-levitt-llp-encourages-investors-with-losses-to-discuss-their-options-with-counsel\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"INVESTOR ALERT: Shareholder Class Action Lawsuit Filed Against TransMedics Group, Inc. (NASDAQ: TMDX); DiCello Levitt LLP Encourages Investors with Losses to Discuss Their Options with Counsel - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SAN DIEGO, Feb. 19, 2025 (GLOBE NEWSWIRE) &#8212; A class action lawsuit has been filed on behalf of all persons and entities who purchased or otherwise acquired TransMedics Group, Inc. (NASDAQ: TMDX) (\u201cTransMedics\u201d or the \u201cCompany\u201d) securities between February 28, 2023 and January 10, 2025 (the \u201cClass Period\u201d), charging the Company and certain senior executives with violations of the federal securities laws (collectively, \u201cDefendants\u201d). TransMedics investors have until April 15, 2025 to seek appointment as lead plaintiff of the TransMedics class action lawsuit. If you purchased or acquired TransMedics securities between February 28, 2023 and January 10, 2025, and suffered substantial losses , and you wish to obtain additional information or serve as lead plaintiff in this lawsuit, you may &hellip; Continue reading &quot;INVESTOR ALERT: Shareholder Class Action Lawsuit Filed Against TransMedics Group, Inc. (NASDAQ: TMDX); DiCello Levitt LLP Encourages Investors with Losses to Discuss Their Options with Counsel&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-shareholder-class-action-lawsuit-filed-against-transmedics-group-inc-nasdaq-tmdx-dicello-levitt-llp-encourages-investors-with-losses-to-discuss-their-options-with-counsel\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-19T22:26:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MTM1OSM2NzU5NDU2IzIyNzUwODI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-shareholder-class-action-lawsuit-filed-against-transmedics-group-inc-nasdaq-tmdx-dicello-levitt-llp-encourages-investors-with-losses-to-discuss-their-options-with-counsel\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-shareholder-class-action-lawsuit-filed-against-transmedics-group-inc-nasdaq-tmdx-dicello-levitt-llp-encourages-investors-with-losses-to-discuss-their-options-with-counsel\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"INVESTOR ALERT: Shareholder Class Action Lawsuit Filed Against TransMedics Group, Inc. (NASDAQ: TMDX); DiCello Levitt LLP Encourages Investors with Losses to Discuss Their Options with Counsel\",\"datePublished\":\"2025-02-19T22:26:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-shareholder-class-action-lawsuit-filed-against-transmedics-group-inc-nasdaq-tmdx-dicello-levitt-llp-encourages-investors-with-losses-to-discuss-their-options-with-counsel\\\/\"},\"wordCount\":833,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-shareholder-class-action-lawsuit-filed-against-transmedics-group-inc-nasdaq-tmdx-dicello-levitt-llp-encourages-investors-with-losses-to-discuss-their-options-with-counsel\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM2MTM1OSM2NzU5NDU2IzIyNzUwODI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-shareholder-class-action-lawsuit-filed-against-transmedics-group-inc-nasdaq-tmdx-dicello-levitt-llp-encourages-investors-with-losses-to-discuss-their-options-with-counsel\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-shareholder-class-action-lawsuit-filed-against-transmedics-group-inc-nasdaq-tmdx-dicello-levitt-llp-encourages-investors-with-losses-to-discuss-their-options-with-counsel\\\/\",\"name\":\"INVESTOR ALERT: Shareholder Class Action Lawsuit Filed Against TransMedics Group, Inc. (NASDAQ: TMDX); DiCello Levitt LLP Encourages Investors with Losses to Discuss Their Options with Counsel - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-shareholder-class-action-lawsuit-filed-against-transmedics-group-inc-nasdaq-tmdx-dicello-levitt-llp-encourages-investors-with-losses-to-discuss-their-options-with-counsel\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-shareholder-class-action-lawsuit-filed-against-transmedics-group-inc-nasdaq-tmdx-dicello-levitt-llp-encourages-investors-with-losses-to-discuss-their-options-with-counsel\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM2MTM1OSM2NzU5NDU2IzIyNzUwODI=\",\"datePublished\":\"2025-02-19T22:26:40+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-shareholder-class-action-lawsuit-filed-against-transmedics-group-inc-nasdaq-tmdx-dicello-levitt-llp-encourages-investors-with-losses-to-discuss-their-options-with-counsel\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-shareholder-class-action-lawsuit-filed-against-transmedics-group-inc-nasdaq-tmdx-dicello-levitt-llp-encourages-investors-with-losses-to-discuss-their-options-with-counsel\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-shareholder-class-action-lawsuit-filed-against-transmedics-group-inc-nasdaq-tmdx-dicello-levitt-llp-encourages-investors-with-losses-to-discuss-their-options-with-counsel\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM2MTM1OSM2NzU5NDU2IzIyNzUwODI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM2MTM1OSM2NzU5NDU2IzIyNzUwODI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-shareholder-class-action-lawsuit-filed-against-transmedics-group-inc-nasdaq-tmdx-dicello-levitt-llp-encourages-investors-with-losses-to-discuss-their-options-with-counsel\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"INVESTOR ALERT: Shareholder Class Action Lawsuit Filed Against TransMedics Group, Inc. (NASDAQ: TMDX); DiCello Levitt LLP Encourages Investors with Losses to Discuss Their Options with Counsel\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"INVESTOR ALERT: Shareholder Class Action Lawsuit Filed Against TransMedics Group, Inc. (NASDAQ: TMDX); DiCello Levitt LLP Encourages Investors with Losses to Discuss Their Options with Counsel - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-shareholder-class-action-lawsuit-filed-against-transmedics-group-inc-nasdaq-tmdx-dicello-levitt-llp-encourages-investors-with-losses-to-discuss-their-options-with-counsel\/","og_locale":"en_US","og_type":"article","og_title":"INVESTOR ALERT: Shareholder Class Action Lawsuit Filed Against TransMedics Group, Inc. (NASDAQ: TMDX); DiCello Levitt LLP Encourages Investors with Losses to Discuss Their Options with Counsel - Market Newsdesk","og_description":"SAN DIEGO, Feb. 19, 2025 (GLOBE NEWSWIRE) &#8212; A class action lawsuit has been filed on behalf of all persons and entities who purchased or otherwise acquired TransMedics Group, Inc. (NASDAQ: TMDX) (\u201cTransMedics\u201d or the \u201cCompany\u201d) securities between February 28, 2023 and January 10, 2025 (the \u201cClass Period\u201d), charging the Company and certain senior executives with violations of the federal securities laws (collectively, \u201cDefendants\u201d). TransMedics investors have until April 15, 2025 to seek appointment as lead plaintiff of the TransMedics class action lawsuit. If you purchased or acquired TransMedics securities between February 28, 2023 and January 10, 2025, and suffered substantial losses , and you wish to obtain additional information or serve as lead plaintiff in this lawsuit, you may &hellip; Continue reading \"INVESTOR ALERT: Shareholder Class Action Lawsuit Filed Against TransMedics Group, Inc. (NASDAQ: TMDX); DiCello Levitt LLP Encourages Investors with Losses to Discuss Their Options with Counsel\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-shareholder-class-action-lawsuit-filed-against-transmedics-group-inc-nasdaq-tmdx-dicello-levitt-llp-encourages-investors-with-losses-to-discuss-their-options-with-counsel\/","og_site_name":"Market Newsdesk","article_published_time":"2025-02-19T22:26:40+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MTM1OSM2NzU5NDU2IzIyNzUwODI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-shareholder-class-action-lawsuit-filed-against-transmedics-group-inc-nasdaq-tmdx-dicello-levitt-llp-encourages-investors-with-losses-to-discuss-their-options-with-counsel\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-shareholder-class-action-lawsuit-filed-against-transmedics-group-inc-nasdaq-tmdx-dicello-levitt-llp-encourages-investors-with-losses-to-discuss-their-options-with-counsel\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"INVESTOR ALERT: Shareholder Class Action Lawsuit Filed Against TransMedics Group, Inc. (NASDAQ: TMDX); DiCello Levitt LLP Encourages Investors with Losses to Discuss Their Options with Counsel","datePublished":"2025-02-19T22:26:40+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-shareholder-class-action-lawsuit-filed-against-transmedics-group-inc-nasdaq-tmdx-dicello-levitt-llp-encourages-investors-with-losses-to-discuss-their-options-with-counsel\/"},"wordCount":833,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-shareholder-class-action-lawsuit-filed-against-transmedics-group-inc-nasdaq-tmdx-dicello-levitt-llp-encourages-investors-with-losses-to-discuss-their-options-with-counsel\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MTM1OSM2NzU5NDU2IzIyNzUwODI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-shareholder-class-action-lawsuit-filed-against-transmedics-group-inc-nasdaq-tmdx-dicello-levitt-llp-encourages-investors-with-losses-to-discuss-their-options-with-counsel\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-shareholder-class-action-lawsuit-filed-against-transmedics-group-inc-nasdaq-tmdx-dicello-levitt-llp-encourages-investors-with-losses-to-discuss-their-options-with-counsel\/","name":"INVESTOR ALERT: Shareholder Class Action Lawsuit Filed Against TransMedics Group, Inc. (NASDAQ: TMDX); DiCello Levitt LLP Encourages Investors with Losses to Discuss Their Options with Counsel - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-shareholder-class-action-lawsuit-filed-against-transmedics-group-inc-nasdaq-tmdx-dicello-levitt-llp-encourages-investors-with-losses-to-discuss-their-options-with-counsel\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-shareholder-class-action-lawsuit-filed-against-transmedics-group-inc-nasdaq-tmdx-dicello-levitt-llp-encourages-investors-with-losses-to-discuss-their-options-with-counsel\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MTM1OSM2NzU5NDU2IzIyNzUwODI=","datePublished":"2025-02-19T22:26:40+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-shareholder-class-action-lawsuit-filed-against-transmedics-group-inc-nasdaq-tmdx-dicello-levitt-llp-encourages-investors-with-losses-to-discuss-their-options-with-counsel\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-shareholder-class-action-lawsuit-filed-against-transmedics-group-inc-nasdaq-tmdx-dicello-levitt-llp-encourages-investors-with-losses-to-discuss-their-options-with-counsel\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-shareholder-class-action-lawsuit-filed-against-transmedics-group-inc-nasdaq-tmdx-dicello-levitt-llp-encourages-investors-with-losses-to-discuss-their-options-with-counsel\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MTM1OSM2NzU5NDU2IzIyNzUwODI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MTM1OSM2NzU5NDU2IzIyNzUwODI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-shareholder-class-action-lawsuit-filed-against-transmedics-group-inc-nasdaq-tmdx-dicello-levitt-llp-encourages-investors-with-losses-to-discuss-their-options-with-counsel\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"INVESTOR ALERT: Shareholder Class Action Lawsuit Filed Against TransMedics Group, Inc. (NASDAQ: TMDX); DiCello Levitt LLP Encourages Investors with Losses to Discuss Their Options with Counsel"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/815237","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=815237"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/815237\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=815237"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=815237"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=815237"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}